Neuroblastoma
Not yet recruitingStudy of ABTL0812 with Irinotecan and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Study of ABTL0812 with Irinotecan and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors
- Disease:Neuroblastoma
- Substances:Sodium 2-HYDROXYLINOLEATE
Spain- Participants:0–17 years · 18–64 years
- Substances:Sodium 2-HYDROXYLINOLEATE
- Sponsor:Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron
